Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuroimmunology|November 1, 2008
Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndromeVongsavanh Phongsisay, Keiichiro Susuki, Kenjiro Matsuno, et al.Frontiers in Neurology|April 11, 2024
Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraineKeisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, et al.Journal of Neurology|August 2, 2024
IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathiesNorito Kokubun, Tomohiro Tsuchiya, Mai Hamaguchi, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2007
Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibersKeiichiro Susuki, Matthew N Rasband, Koujiro Tohyama, et al.Journal of the Neurological Sciences|March 21, 2006
Severe cranial nerve involvement in a patient with monoclonal anti-MAG/SGPG IgM antibody and localized hard palate amyloidosisTakuhiro Yoshida, Masahide Yazaki, Takahisa Gono, et al.Experimental and Therapeutic Medicine|February 4, 2020
Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case reportManabu Miyamoto, George Imataka, Go Ichikawa, et al.Journal of Parkinson'S Disease|March 29, 2021
Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi PrefectureKeisuke Suzuki, Ayaka Numao, Tomoko Komagamine, et al.Internal Medicine (Tokyo, Japan)|April 1, 2026
Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal AntibodiesSo Okubo, Yuki Nagasako, Fumiko Kusunoki Nakamoto, et al.Pageof 3